Increased γ-secretase activity in idiopathic normal pressure hydrocephalus patients with β-amyloid pathology

PLoS One. 2014 Apr 3;9(4):e93717. doi: 10.1371/journal.pone.0093717. eCollection 2014.

Abstract

The potential similarity between the brain pathology of idiopathic normal pressure hydrocephalus (iNPH) and Alzheimer disease (AD) is intriguing and thus further studies focusing on the underlying molecular mechanisms may offer valuable information for differential diagnostics and the development of treatments for iNPH. Here, we investigated β- and γ-secretase activities in relation to amyloid-β (Aβ) pathology in the brain tissue samples collected from iNPH and AD patients. β- and γ-secretase activities were measured from the frontal cortical biopsies of 26 patients with suspected iNPH as well as post-mortem tissue samples from the inferior temporal cortex of 74 AD patients and eight subjects without neurofibrillary pathology. In iNPH samples with detectable Aβ plaques, γ-secretase activity was significantly increased (∼ 1.6-fold) when compared to iNPH samples without Aβ plaques (p = 0.009). In the AD samples, statistically significant differences in the γ-secretase activity were not observed with respect to disease severity (mild, moderate and severe AD according to neurofibrillary pathology). Conversely, β-secretase activity was unaltered in iNPH samples with or without Aβ plaques, while it was significantly increased in relation to disease severity in the AD patients. These results show for the first time increased γ-secretase but not β-secretase activity in the biopsy samples from the frontal cortex of iNPH patients with AD-like Aβ pathology. Conversely, the opposite was observed in these secretase activities in AD patients with respect to neurofibrillary pathology. Despite the resemblances in the Aβ pathology, iNPH and AD patients appear to have marked differences in the cellular mechanisms responsible for the production of Aβ.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology
  • Amyloid Precursor Protein Secretases / metabolism*
  • Amyloid beta-Peptides / metabolism*
  • Female
  • Frontal Lobe / metabolism*
  • Frontal Lobe / pathology
  • Humans
  • Hydrocephalus, Normal Pressure / metabolism*
  • Hydrocephalus, Normal Pressure / pathology
  • Male

Substances

  • Amyloid beta-Peptides
  • Amyloid Precursor Protein Secretases

Grants and funding

This study was funded by the Academy of Finland, EVO grant 5772708 of Kuopio University Hospital, Sigrid Juselius Foundation, and the Strategic Funding of the University of Eastern Finland (UEF-Brain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.